I have 25 years of experience, and specialize in the field of analytical and bioanalytical research and development with specific knowledge in the areas of dystrophia myotonica-protein kinase (DMPK), preclinical and clinical. I have published on such topics as bioanalytical methods for bioavailability (BA), bioequivalence (BE) and other related studies and discovery to concept. I have testified on drug testing data is reliability, accuracy and convincability.